AU3945393A - Treatment of hepatitis with GM-CSF - Google Patents

Treatment of hepatitis with GM-CSF

Info

Publication number
AU3945393A
AU3945393A AU39453/93A AU3945393A AU3945393A AU 3945393 A AU3945393 A AU 3945393A AU 39453/93 A AU39453/93 A AU 39453/93A AU 3945393 A AU3945393 A AU 3945393A AU 3945393 A AU3945393 A AU 3945393A
Authority
AU
Australia
Prior art keywords
csf
hepatitis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39453/93A
Inventor
Eric M. Bonnem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU3945393A publication Critical patent/AU3945393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
AU39453/93A 1992-04-14 1993-04-12 Treatment of hepatitis with GM-CSF Abandoned AU3945393A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86859792A 1992-04-14 1992-04-14
US868597 1992-04-14

Publications (1)

Publication Number Publication Date
AU3945393A true AU3945393A (en) 1993-11-18

Family

ID=25351970

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39453/93A Abandoned AU3945393A (en) 1992-04-14 1993-04-12 Treatment of hepatitis with GM-CSF

Country Status (6)

Country Link
CN (1) CN1085802A (en)
AU (1) AU3945393A (en)
IL (1) IL105387A0 (en)
MX (1) MX9302138A (en)
WO (1) WO1993020835A1 (en)
ZA (1) ZA932603B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT858343E (en) * 1995-11-02 2004-07-30 Schering Corp THERAPY FOR CONTINUOUS INFUSE OF A LOW DOSE OF CYTOKINE
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294160A1 (en) * 1987-06-02 1988-12-07 Schering Corporation Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons
KR960014097B1 (en) * 1988-11-09 1996-10-14 쉐링 코포레이션 Composition for treatment of syndroms associated with cytomegalovirus retinitis

Also Published As

Publication number Publication date
CN1085802A (en) 1994-04-27
ZA932603B (en) 1993-10-13
WO1993020835A1 (en) 1993-10-28
MX9302138A (en) 1993-10-01
IL105387A0 (en) 1993-08-18

Similar Documents

Publication Publication Date Title
AU673703B2 (en) Injector and use of the same
AU3693493A (en) Pyloroplasty/pylorectomy shield
AU4165993A (en) Aminediol compounds and derivatives and halohydrin intermediates
AU4013193A (en) Method of maintaining relationships between elements
AU664775B2 (en) An article of furniture
AU4865593A (en) Cooking range
AU5044393A (en) Stereoselective reduction of ketones
AU118073S (en) Set of utensils
AU4772493A (en) Sulfo-derivatives of adenosine
AU1169092A (en) Method of brazing
AU3950193A (en) Cannula
AU4444993A (en) Heat treatment
AU4219793A (en) Syringe
AU3730093A (en) Methods of treating diabetes
AU8427091A (en) Gamma-carboxylase and methods of use
AU5666994A (en) T-configured wheelchair
AU7185191A (en) Oxidized variants of gm-csf
AU3423693A (en) Methods of terminating pregnancy
AU4720593A (en) Coating of components
AU5371694A (en) Use of the tarchonanthus camphoratus
AU3945393A (en) Treatment of hepatitis with GM-CSF
AU3641993A (en) Treatment chamber
AU5149793A (en) Method of preparing aminoalkylhydantoins and aminoalkyl-alpha-aminoacids
AU4419693A (en) Micro-emulsion of dexniguldipin
AU4272293A (en) Apoptosis inducer